-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Akebia Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
- Akebia Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $1.4M, unchanged year-over-year.
- Akebia Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $5.6M, a 11.1% decline year-over-year.
- Akebia Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $5.9M, a 18.1% decline from 2022.
- Akebia Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $7.2M, a 1.41% increase from 2021.
- Akebia Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $7.1M, a 1.43% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)